112 related articles for article (PubMed ID: 16018855)
1. Effects of carvedilol upon intra- and interventricular synchrony in patients with chronic heart failure.
Castro PF; Mc-Nab P; Quintana JC; Bittner A; Greig D; Vergara I; Vukasovic JL; Corbalan R; Copaja M; Díaz-Araya G; Chiong M; Troncoso R; Alcaino H; Lavandero S
Am J Cardiol; 2005 Jul; 96(2):267-9. PubMed ID: 16018855
[TBL] [Abstract][Full Text] [Related]
2. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
[TBL] [Abstract][Full Text] [Related]
3. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
Palazzuoli A; Bruni F; Puccetti L; Pastorelli M; Angori P; Pasqui AL; Auteri A
Eur J Heart Fail; 2002 Dec; 4(6):765-70. PubMed ID: 12453548
[TBL] [Abstract][Full Text] [Related]
4. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study.
Hori M; Nagai R; Izumi T; Matsuzaki M
Heart Vessels; 2014 Mar; 29(2):238-47. PubMed ID: 23559359
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
[TBL] [Abstract][Full Text] [Related]
7. Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.
Udelson JE; Pressler SJ; Sackner-Bernstein J; Massaro J; Ordronneau P; Lukas MA; Hauptman PJ
J Card Fail; 2009 Jun; 15(5):385-93. PubMed ID: 19477398
[TBL] [Abstract][Full Text] [Related]
8. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
[TBL] [Abstract][Full Text] [Related]
9. Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study.
Opasich C; De Feo S; Cioffi G; Pulignano G; Del Sindaco D; Tarantini L; Gualco A; Patrignani A
Ital Heart J; 2005 Apr; 6(4):323-7. PubMed ID: 15902931
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.
Armenian SH; Hudson MM; Chen MH; Colan SD; Lindenfeld L; Mills G; Siyahian A; Gelehrter S; Dang H; Hein W; Green DM; Robison LL; Wong FL; Douglas PS; Bhatia S
BMC Cardiovasc Disord; 2016 Oct; 16(1):187. PubMed ID: 27716152
[TBL] [Abstract][Full Text] [Related]
11. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
[TBL] [Abstract][Full Text] [Related]
12. A COMET lost.
Goldstein S
Ital Heart J; 2003 Oct; 4(10):653-4. PubMed ID: 14664277
[No Abstract] [Full Text] [Related]
13. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
14. Beta-blocker dosing in community-based treatment of heart failure.
Fowler MB; Lottes SR; Nelson JJ; Lukas MA; Gilbert EM; Greenberg B; Massie BM; Abraham WT; Franciosa JA;
Am Heart J; 2007 Jun; 153(6):1029-36. PubMed ID: 17540206
[TBL] [Abstract][Full Text] [Related]
15. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.
Kotlyar E; Keogh AM; Macdonald PS; Arnold RH; McCaffrey DJ; Glanville AR
J Heart Lung Transplant; 2002 Dec; 21(12):1290-5. PubMed ID: 12490274
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
18. N-terminal prohormone brain natriuretic peptide plasma levels in heart failure are affected both directly and indirectly by carvedilol.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
Angiology; 2008; 59(3):323-8. PubMed ID: 18388105
[TBL] [Abstract][Full Text] [Related]
19. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers.
Lindenfeld J; Robertson AD; Lowes BD; Bristow MR;
J Am Coll Cardiol; 2001 Dec; 38(7):1950-6. PubMed ID: 11738299
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
